SPY423.58+2.72 0.65%
DIA340.05+1.27 0.37%
IXIC14,254.31+112.83 0.80%

--HC Wainwright Adjusts VYNE Therapeutics' Price Target to $11 from $14, Keeps Buy Rating

05/07/2021 09:50

01:36 PM EDT, 05/07/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 3.61, Change: +0.05, Percent Change: +1.26